Nizatidine
Overview
Nizatidine is a histamine H2 receptor antagonist that inhibits stomach acid production. It is used in the treatment of peptic ulcer disease and gastroesophageal reflux disease (GERD).
API suppliers (5)
Suppliers of Nizatidine evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
Country recorded for 3 of 5 suppliers.
3 of 5 hold a GMP certificate on record in the EU or UK registers
- SOLARA ACTIVE PHARMA SCIENCES LTDIndia1 active DMF GMP on record
- DR REDDYS LABORATORIES LTD1 active DMF GMP on record
- EURO CHEMI INC
- Wockhardt UsaUnited Kingdom
- OLON SPAItaly GMP on record
EU CEP holders (2)
Companies holding a valid EU Certificate of Suitability (CEP) for Nizatidine, from the EDQM certification database. A CEP holder is a documented EU-market source of the substance — not necessarily the manufacturer — and these are not yet profiled in our directory.
Therapeutic areas
Do you supply Nizatidine? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.